APO Research
Talk to an analyst

APO RESEARCH · REPORT

Imipenem

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Imipenem Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchImipenem Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Imipenem Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Imipenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Imipenem Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Imipenem Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Imipenem market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Imipenem market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Imipenem market include Sun Pharmaceutical Industries, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical, Savior Lifetec, HISUN Pharmaceutical and HISOAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Imipenem market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Imipenem and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Imipenem sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Imipenem market size, projected growth trends, production technologies, key applications, and end-use industries.

Imipenem Segment by Company

Sun Pharmaceutical Industries

Haibin Pharmaceutical

Jiangxi Fushine Pharmaceutical

Savior Lifetec

HISUN Pharmaceutical

HISOAR

Imipenem Segment by Type

Sterile Type

Non-sterile Type

Imipenem Segment by Application

Injection

Other

Imipenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Imipenem status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Imipenem market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Imipenem significant trends, drivers, influence factors in global and regions.

6. To analyze Imipenem competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Imipenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Imipenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Imipenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Imipenem market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Imipenem industry.

Chapter 3: Detailed analysis of Imipenem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Imipenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Imipenem in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Imipenem Industry Trends Table 2. Imipenem Industry Drivers Table 3. Imipenem Industry Opportunities and Challenges Table 4. Imipenem Industry Restraints Table 5. Global Imipenem Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Imipenem Revenue Share by Company (2021-2026) Table 7. Global Imipenem Sales Volume by Company (kg) & (2021-2026) Table 8. Global Imipenem Sales Volume Share by Company (2021-2026) Table 9. Global Imipenem Average Price (US$/kg) of Company (2021-2026) Table 10. Global Imipenem Company Ranking, (2024-2026) & (USD Million) Table 11. Global Imipenem Key Company Manufacturing Base & Headquarters Table 12. Global Imipenem Company, Product Type & Application Table 13. Global Imipenem Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Imipenem by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sterile Type Table 18. Significant Companies of Non-sterile Type Table 19. Global Imipenem Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Imipenem Sales Volume by Type (2021-2026) & (kg) Table 21. Global Imipenem Sales Volume by Type (2027-2032) & (kg) Table 22. Global Imipenem Sales Volume Share by Type (2021-2026) Table 23. Global Imipenem Sales Volume Share by Type (2027-2032) Table 24. Global Imipenem Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Imipenem Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Imipenem Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Imipenem Sales Value Share by Type (2021-2026) Table 28. Global Imipenem Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injection Table 30. Significant Companies of Other Table 31. Global Imipenem Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Imipenem Sales Volume by Application (2021-2026) & (kg) Table 33. Global Imipenem Sales Volume by Application (2027-2032) & (kg) Table 34. Global Imipenem Sales Volume Share by Application (2021-2026) Table 35. Global Imipenem Sales Volume Share by Application (2027-2032) Table 36. Global Imipenem Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Imipenem Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Imipenem Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Imipenem Sales Value Share by Application (2021-2026) Table 40. Global Imipenem Sales Value Share by Application (2027-2032) Table 41. Global Imipenem Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Imipenem Sales by Region (2021-2026) & (kg) Table 43. Global Imipenem Sales Market Share by Region (2021-2026) Table 44. Global Imipenem Sales by Region (2027-2032) & (kg) Table 45. Global Imipenem Sales Market Share by Region (2027-2032) Table 46. Global Imipenem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Imipenem Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Imipenem Sales Value Share by Region (2021-2026) Table 49. Global Imipenem Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Imipenem Sales Value Share by Region (2027-2032) Table 51. Global Imipenem Market Average Price (US$/kg) by Region (2021-2026) Table 52. Global Imipenem Market Average Price (US$/kg) by Region (2027-2032) Table 53. Global Imipenem Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Global Imipenem Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Imipenem Sales by Country (2021-2026) & (kg) Table 56. Global Imipenem Sales Market Share by Country (2021-2026) Table 57. Global Imipenem Sales by Country (2027-2032) & (kg) Table 58. Global Imipenem Sales Market Share by Country (2027-2032) Table 59. Global Imipenem Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Imipenem Sales Value Market Share by Country (2021-2026) Table 61. Global Imipenem Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Imipenem Sales Value Market Share by Country (2027-2032) Table 63. Sun Pharmaceutical Industries Company Information Table 64. Sun Pharmaceutical Industries Business Overview Table 65. Sun Pharmaceutical Industries Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Industries Imipenem Product Portfolio Table 67. Sun Pharmaceutical Industries Recent Development Table 68. Haibin Pharmaceutical Company Information Table 69. Haibin Pharmaceutical Business Overview Table 70. Haibin Pharmaceutical Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Haibin Pharmaceutical Imipenem Product Portfolio Table 72. Haibin Pharmaceutical Recent Development Table 73. Jiangxi Fushine Pharmaceutical Company Information Table 74. Jiangxi Fushine Pharmaceutical Business Overview Table 75. Jiangxi Fushine Pharmaceutical Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio Table 77. Jiangxi Fushine Pharmaceutical Recent Development Table 78. Savior Lifetec Company Information Table 79. Savior Lifetec Business Overview Table 80. Savior Lifetec Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Savior Lifetec Imipenem Product Portfolio Table 82. Savior Lifetec Recent Development Table 83. HISUN Pharmaceutical Company Information Table 84. HISUN Pharmaceutical Business Overview Table 85. HISUN Pharmaceutical Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. HISUN Pharmaceutical Imipenem Product Portfolio Table 87. HISUN Pharmaceutical Recent Development Table 88. HISOAR Company Information Table 89. HISOAR Business Overview Table 90. HISOAR Imipenem Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. HISOAR Imipenem Product Portfolio Table 92. HISOAR Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Imipenem Distributors List Table 96. Imipenem Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Imipenem Product Image Figure 2. Global Imipenem Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Imipenem Sales Value (2021-2032) & (US$ Million) Figure 4. Global Imipenem Sales (2021-2032) & (kg) Figure 5. Global Imipenem Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Imipenem Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sterile Type Image Figure 10. Non-sterile Type Image Figure 11. Global Imipenem Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Imipenem Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Imipenem Sales Volume Share by Type (2021-2032) Figure 14. Global Imipenem Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Imipenem Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Imipenem Sales Value Share by Type (2021-2032) Figure 17. Injection Image Figure 18. Other Image Figure 19. Global Imipenem Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Imipenem Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Imipenem Sales Volume Share by Application (2021-2032) Figure 22. Global Imipenem Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Imipenem Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Imipenem Sales Value Share by Application (2021-2032) Figure 25. Global Imipenem Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 26. Global Imipenem Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Imipenem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Imipenem Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Imipenem Sales Value (2021-2032) & (US$ Million) Figure 30. North America Imipenem Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Imipenem Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Imipenem Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Imipenem Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Imipenem Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Imipenem Sales Value (2021-2032) & (US$ Million) Figure 36. South America Imipenem Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Imipenem Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Imipenem Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Imipenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Imipenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Imipenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Imipenem Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Imipenem Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Sterile Type
  • Non-sterile Type
Applications
  • Injection
  • Other
Companies covered
  • Sun Pharmaceutical Industries
  • Haibin Pharmaceutical
  • Jiangxi Fushine Pharmaceutical
  • Savior Lifetec
  • HISUN Pharmaceutical
  • HISOAR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Imipenem Sales Value (2021-2032)
  4. 1.2.2 Global Imipenem Sales Volume (2021-2032)
  5. 1.2.3 Global Imipenem Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Imipenem Market Dynamics
  1. 2.1 Imipenem Industry Trends
  2. 2.2 Imipenem Industry Drivers
  3. 2.3 Imipenem Industry Opportunities and Challenges
  4. 2.4 Imipenem Industry Restraints
3 Imipenem Market by Company
  1. 3.1 Global Imipenem Company Revenue Ranking in 2025
  2. 3.2 Global Imipenem Revenue by Company (2021-2026)
  3. 3.3 Global Imipenem Sales Volume by Company (2021-2026)
  4. 3.4 Global Imipenem Average Price by Company (2021-2026)
  5. 3.5 Global Imipenem Company Ranking (2024-2026)
  6. 3.6 Global Imipenem Company Manufacturing Base and Headquarters
  7. 3.7 Global Imipenem Company Product Type and Application
  8. 3.8 Global Imipenem Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Imipenem Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Imipenem Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Imipenem Market by Type
  1. 4.1 Imipenem Type Introduction
  2. 4.1.1 Sterile Type
  3. 4.1.2 Non-sterile Type
  4. 4.2 Global Imipenem Sales Volume by Type
  5. 4.2.1 Global Imipenem Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Imipenem Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Imipenem Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Imipenem Sales Value by Type
  9. 4.3.1 Global Imipenem Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Imipenem Sales Value by Type (2021-2032)
  11. 4.3.3 Global Imipenem Sales Value Share by Type (2021-2032)
5 Imipenem Market by Application
  1. 5.1 Imipenem Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Other
  4. 5.2 Global Imipenem Sales Volume by Application
  5. 5.2.1 Global Imipenem Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Imipenem Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Imipenem Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Imipenem Sales Value by Application
  9. 5.3.1 Global Imipenem Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Imipenem Sales Value by Application (2021-2032)
  11. 5.3.3 Global Imipenem Sales Value Share by Application (2021-2032)
6 Imipenem Regional Sales and Value Analysis
  1. 6.1 Global Imipenem Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Imipenem Sales by Region (2021-2032)
  3. 6.2.1 Global Imipenem Sales by Region: 2021-2026
  4. 6.2.2 Global Imipenem Sales by Region (2027-2032)
  5. 6.3 Global Imipenem Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Imipenem Sales Value by Region (2021-2032)
  7. 6.4.1 Global Imipenem Sales Value by Region: 2021-2026
  8. 6.4.2 Global Imipenem Sales Value by Region (2027-2032)
  9. 6.5 Global Imipenem Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Imipenem Sales Value (2021-2032)
  12. 6.6.2 North America Imipenem Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Imipenem Sales Value (2021-2032)
  15. 6.7.2 Europe Imipenem Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Imipenem Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Imipenem Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Imipenem Sales Value (2021-2032)
  21. 6.9.2 South America Imipenem Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Imipenem Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Imipenem Sales Value Share by Country, 2025 VS 2032
7 Imipenem Country-level Sales and Value Analysis
  1. 7.1 Global Imipenem Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Imipenem Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Imipenem Sales by Country (2021-2032)
  4. 7.3.1 Global Imipenem Sales by Country (2021-2026)
  5. 7.3.2 Global Imipenem Sales by Country (2027-2032)
  6. 7.4 Global Imipenem Sales Value by Country (2021-2032)
  7. 7.4.1 Global Imipenem Sales Value by Country (2021-2026)
  8. 7.4.2 Global Imipenem Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Imipenem Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Imipenem Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Imipenem Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Imipenem Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Imipenem Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Imipenem Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Imipenem Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Imipenem Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Imipenem Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Imipenem Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Imipenem Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Imipenem Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Imipenem Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Imipenem Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Imipenem Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Imipenem Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Imipenem Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Imipenem Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Imipenem Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Imipenem Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Imipenem Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Imipenem Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Imipenem Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Imipenem Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Imipenem Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Imipenem Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Imipenem Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Imipenem Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Imipenem Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Imipenem Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Imipenem Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Imipenem Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Imipenem Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Imipenem Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Imipenem Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Imipenem Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Imipenem Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Imipenem Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Imipenem Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Imipenem Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Imipenem Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Imipenem Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Imipenem Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Imipenem Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Imipenem Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Imipenem Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Imipenem Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Imipenem Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Imipenem Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Imipenem Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Imipenem Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Imipenem Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Imipenem Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Imipenem Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Imipenem Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Imipenem Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Imipenem Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Imipenem Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Imipenem Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Imipenem Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Imipenem Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Imipenem Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Imipenem Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Imipenem Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Imipenem Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Imipenem Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Imipenem Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Imipenem Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Imipenem Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Imipenem Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Imipenem Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Imipenem Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Imipenem Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Imipenem Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Imipenem Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Imipenem Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Imipenem Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Imipenem Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Imipenem Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Imipenem Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Imipenem Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Imipenem Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Imipenem Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Imipenem Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Imipenem Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Imipenem Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Haibin Pharmaceutical
  8. 8.2.1 Haibin Pharmaceutical Company Information
  9. 8.2.2 Haibin Pharmaceutical Business Overview
  10. 8.2.3 Haibin Pharmaceutical Imipenem Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Haibin Pharmaceutical Imipenem Product Portfolio
  12. 8.2.5 Haibin Pharmaceutical Recent Developments
  13. 8.3 Jiangxi Fushine Pharmaceutical
  14. 8.3.1 Jiangxi Fushine Pharmaceutical Company Information
  15. 8.3.2 Jiangxi Fushine Pharmaceutical Business Overview
  16. 8.3.3 Jiangxi Fushine Pharmaceutical Imipenem Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio
  18. 8.3.5 Jiangxi Fushine Pharmaceutical Recent Developments
  19. 8.4 Savior Lifetec
  20. 8.4.1 Savior Lifetec Company Information
  21. 8.4.2 Savior Lifetec Business Overview
  22. 8.4.3 Savior Lifetec Imipenem Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Savior Lifetec Imipenem Product Portfolio
  24. 8.4.5 Savior Lifetec Recent Developments
  25. 8.5 HISUN Pharmaceutical
  26. 8.5.1 HISUN Pharmaceutical Company Information
  27. 8.5.2 HISUN Pharmaceutical Business Overview
  28. 8.5.3 HISUN Pharmaceutical Imipenem Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HISUN Pharmaceutical Imipenem Product Portfolio
  30. 8.5.5 HISUN Pharmaceutical Recent Developments
  31. 8.6 HISOAR
  32. 8.6.1 HISOAR Company Information
  33. 8.6.2 HISOAR Business Overview
  34. 8.6.3 HISOAR Imipenem Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 HISOAR Imipenem Product Portfolio
  36. 8.6.5 HISOAR Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Imipenem Value Chain Analysis
  2. 9.1.1 Imipenem Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Imipenem Sales Mode & Process
  6. 9.2 Imipenem Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Imipenem Distributors
  9. 9.2.3 Imipenem Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst